Glenview Capital Management
GLENVIEW CAPITAL MANAGEMENT, LLC · CIK 0001138995 · NEW YORK, NY · Dönem sonu: 2026-06-30 · Dosyalama tarihi: 2026-08-14 · SEC kaynağını aç ↗Aktivist Yatırımcı
Portföy BüyüklüğüFonun SEC’e bildirdiği ABD hisse portföyünün toplam değeri.
$5.49B
2026 Q2
Pozisyon
45
İlk 10 Hissenin AğırlığıPortföyün ne kadarının en büyük 10 hissede toplandığı. Yüksekse fon az sayıda hisseye odaklanıyor.
60.7%
Para Girişi/Çıkışı (Tahmini)
—
2026 Q2
Portföy Büyüklüğü Geçmişi
Çeyreklik Geçmiş · 40 Çeyrek
| Çeyrek | Bildirim | Pozisyon | Toplam Değer | Devir % | İlk 10 |
|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | 42 | $5.49B | 21.2% | GPN, CVS, THC, TMO, AMZN, A, DHR, META, AMD, TEVA |
| 2026 Q1 | 2026-05-15 | 41 | $3.98B | 14.0% | CVS, GPN, THC, AMZN, TEVA, CI, AMD, TMO, VTRS, DXC |
| 2025 Q4 | 2026-02-17 | 54 | $4.91B | 20.9% | CVS, TEVA, GPN, THC, AMZN, GTM, VTRS, TMO, DXC, DOCN |
| 2025 Q3 | 2025-11-14 | 53 | $4.49B | 13.1% | CVS, THC, GPN, TEVA, GTM, AMZN, TMO, DXC, UHS, PYPL |
| 2025 Q2 | 2025-08-14 | 42 | $3.57B | 18.4% | CVS, THC, GPN, TEVA, GTM, ALITEUR, AMZN, CI, USFD, DXC |
| 2025 Q1 | 2025-05-15 | 44 | $4.07B | 9.6% | CVS, THC, GPN, TEVA, ALITEUR, UHS, AMZN, GTM, CI, DXC |
| 2024 Q4 | 2025-02-14 | 36 | $3.96B | 10.6% | CVS, GPN, THC, ALITEUR, TEVA, 26484T106, CI, EXPE, UHS, DXC |
| 2024 Q3 | 2024-11-14 | 43 | $5.17B | 8.6% | CVS, THC, GPN, CI, CTVA, DXC, G21810109, UHS, EXPE, TEVA |
| 2024 Q2 | 2024-08-14 | 46 | $5.08B | 7.4% | THC, CVS, CI, GPN, CTVA, ALITEUR, UHS, ESI, DXC, MCK |
| 2024 Q1 | 2024-05-15 | 43 | $5.72B | 4.8% | THC, CI, CTVA, UHS, GPN, ALITEUR, DXC, ESI, G21810109, MCK |
| 2023 Q4 | 2024-02-14 | 41 | $4.68B | 11.9% | CI, THC, DXC, UHS, GPN, G21810109, CTVA, ALITEUR, MCK, FISV |
| 2023 Q3 | 2023-11-14 | 47 | $4.42B | 10.7% | THC, CI, UHS, GPN, DXC, MCK, FISV, G21810109, AMZN, ALITEUR |
| 2023 Q2 | 2023-08-14 | 46 | $4.44B | 9.3% | CI, THC, DXC, UHS, GPN, G21810109, MCK, ALITEUR, CTVA, USFD |
| 2023 Q1 | 2023-05-15 | 53 | $4.56B | 14.4% | CI, THC, FISV, GPN, DXC, MCK, VVV, USFD, ALITEUR, HCA |
| 2022 Q4 | 2023-02-14 | 51 | $4.51B | 13.5% | CI, THC, DXC, FISV, MCK, GPN, USFD, UHS, G25839104, VVV |
| 2022 Q3 | 2022-11-14 | 53 | $4.00B | 11.4% | CI, THC, FISV, DXC, GPN, MCK, G6095L109, AMZN, USFD, BAX |
| 2022 Q2 | 2022-08-11 | 53 | $4.00B | 17.9% | CI, THC, GPN, DXC, MCK, FISV, G25839104, USFD, BAX, G6095L109 |
| 2022 Q1 | 2022-05-16 | 58 | $4.94B | 26.2% | THC, CI, GPN, MCK, DXC, FISV, BHC, BAX, USFD, G25839104 |
| 2021 Q2 | 2022-02-18 | 65 | $6.05B | 195.5% | THC, BHC, CI, MCK, DXC, 0VVB, COR, GPN, TAK, UHS |
| 2021 Q3 | 2022-02-18 | 2 | $55.1M | 192.0% | 74765K105, EVLV |
| 2021 Q4 | 2022-02-14 | 54 | $4.69B | 36.5% | THC, MCK, BHC, GPN, CI, BAX, DXC, G25839104, COR, HCA |
| 2021 Q1 | 2021-05-17 | 63 | $5.90B | 14.6% | THC, BHC, CI, MCK, DXC, TAK, COR, HCA, UHS, META |
| 2020 Q4 | 2021-02-16 | 54 | $4.36B | 5.1% | THC, BHC, TAK, DXC, CI, HCA, MCK, 50540R409, LYFT, NUANEUR |
| 2020 Q3 | 2020-11-16 | 45 | $3.19B | 4.1% | THC, TAK, BHC, CI, HCA, MCK, DXC, 50540R409, HO1, 0VVB |
| 2020 Q2 | 2020-08-14 | 43 | $3.63B | 18.5% | THC, TAK, BHC, CI, HCA, DXC, MCK, 0VVB, NUANEUR, 50540R409 |
| 2020 Q1 | 2020-05-15 | 44 | $3.68B | 23.9% | TAK, THC, CI, BHC, HCA, MCK, IQV, FMC, DXC, HO1 |
| 2019 Q4 | 2020-02-14 | 50 | $11.42B | 16.6% | HCA, CI, THC, 0VVB, TAK, IQV, HO1, MCK, BHC, DXC |
| 2019 Q3 | 2019-11-14 | 49 | $9.51B | 13.1% | CI, HCA, MCK, IQV, TAK, THC, HO1, HUM, FMC, DXC |
| 2019 Q2 | 2019-08-14 | 46 | $11.03B | 3.5% | CI, HCA, IQV, FMC, MCK, DXC, HO1, TAK, HUM, 32008D106 |
| 2019 Q1 | 2019-05-15 | 45 | $11.21B | 33.5% | DXC, FMC, CI, MCK, IQV, HCA, TAK, HO1, THC, GOOGL |
| 2018 Q4 | 2019-02-14 | 48 | $10.33B | 27.4% | 82481R106, FMC, IQV, HCA, CVS, CI, MCK, DXC, GOOGL, 26078J100 |
| 2018 Q3 | 2018-11-14 | 57 | $15.74B | 6.5% | 30219G108, FMC, 00817Y108, IQV, MCK, 26078J100, HCA, TMO, 32008D106, 82481R106 |
| 2018 Q2 | 2018-08-14 | 50 | $14.66B | 7.4% | 82481R106, 26078J100, FMC, MCK, THC, IQV, 00817Y108, 32008D106, HCA, 30219G108 |
| 2018 Q1 | 2018-05-15 | 53 | $17.10B | 9.2% | HCA, 82481R106, 26078J100, FMC, IQV, NWL, MCK, TMO, WBA, Y2573F102 |
| 2017 Q4 | 2018-02-14 | 58 | $18.50B | 22.8% | HCA, 26078J100, FMC, 82481R106, IQV, Y2573F102, ELV, DXC, TMO, MCK |
| 2017 Q3 | 2017-11-14 | 56 | $17.23B | 18.4% | HCA, 26078J100, FMC, 82481R106, 74876Y101, ELV, DXC, Y2573F102, 00817Y108, GOOGL |
| 2017 Q2 | 2017-08-14 | 52 | $15.41B | 13.8% | HCA, FMC, 260543103, 74876Y101, ELV, 125509109, DXC, Y2573F102, GOOGL, LOW |
| 2017 Q1 | 2017-05-15 | 51 | $15.07B | 9.3% | HCA, HUM, ELV, 260543103, FMC, 125509109, 00817Y108, 205363104, 74876Y101, GOOGL |
| 2016 Q4 | 2017-02-14 | 48 | $14.79B | 10.6% | HCA, HUM, ELV, 125509109, 00817Y108, GOOGL, ABBV, FMC, 50540R409, Y2573F102 |
| 2016 Q3 | 2016-11-14 | 50 | $13.98B | — | HUM, HCA, 125509109, 124857202, ELV, 00817Y108, 50540R409, Y2573F102, FMC, TMO |
Adetler bölünme düzeltmeli (split-adjusted). Elde tutma süresi, en son çeyrekle biten kesintisiz çeyrek sayısından hesaplanır; 10 yıl üstü ">10 Yıl" olarak gösterilir.
Benzer portföyler
Son çeyrekte tutulan hisselerin Jaccard benzerliğine göre en yakın beş usta yatırımcı (gece hesaplanır).
| Fon | Örtüşme | Ortak hisseler |
|---|---|---|
| Sachem Head Capital Management | 10.9% | BRKR, DKS, PRMB, STM, MKSI, FUN |
| Tiger Global Management | 8.6% | DHR, XYZ, META, AMZN, UBER, AMD, AMAT |
| Dodge & Cox | 8.0% | BSX, CI, CVS, DHR, HUM, LLY, MCHP, TMO +6 |
| Hound Partners | 7.2% | HUM, ELV, META, AMZN, UBER |
| Weitz Investment Management | 7.0% | DHR, TMO, META, GPN, AMZN, TECH |
2026-Q2 çeyrek raporunu oku · 13F Bildirim Takvimi
13F verisi çeyrek sonu pozisyonlarını gösterir, 45 güne kadar gecikmelidir ve yalnızca ABD borsalarındaki uzun (long) pozisyonları kapsar; açığa satışlar, türevler ve ABD dışı varlıklar bildirilmez.